TY - JOUR
T1 - Anthrax as a biological weapon, 2002
T2 - Updated recommendations for management
AU - Inglesby, Thomas V.
AU - O'Toole, Tara
AU - Henderson, Donald A.
AU - Bartlett, John G.
AU - Ascher, Michael S.
AU - Eitzen, Edward
AU - Friedlander, Arthur M.
AU - Gerberding, Julie
AU - Hauer, Jerome
AU - Hughes, James
AU - McDade, Joseph
AU - Osterholm, Michael T.
AU - Parker, Gerald
AU - Perl, Trish M.
AU - Russell, Philip K.
AU - Tonat, Kevin
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2002/5/1
Y1 - 2002/5/1
N2 - Objective: To review and update consensus-based recommendations for medical and public health professionals following a Bacillus anthracis attack against a civilian population. Participants: The working group included 23 experts from academic medical centers, research organizations and governmental, military, public health, and emergency management institutions and agencies. Evidence: MEDLINE databases were searched from January 1966 to January 2002, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Reference review identified work published before 1966. Participants identified unpublished sources. Consensus Process: The first draft synthesized the gathered information. Written comments were incorporated into subsequent drafts. The final statement incorporated all relevant evidence from the search along with consensus recommendations. Conclusions: Specific recommendations include diagnosis of anthrax infection, indications for vaccination, therapy, postexposure prophylaxis, decontamination of the environment, and suggested research. This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the anthrax attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; current anthrax vaccine information; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination.
AB - Objective: To review and update consensus-based recommendations for medical and public health professionals following a Bacillus anthracis attack against a civilian population. Participants: The working group included 23 experts from academic medical centers, research organizations and governmental, military, public health, and emergency management institutions and agencies. Evidence: MEDLINE databases were searched from January 1966 to January 2002, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Reference review identified work published before 1966. Participants identified unpublished sources. Consensus Process: The first draft synthesized the gathered information. Written comments were incorporated into subsequent drafts. The final statement incorporated all relevant evidence from the search along with consensus recommendations. Conclusions: Specific recommendations include diagnosis of anthrax infection, indications for vaccination, therapy, postexposure prophylaxis, decontamination of the environment, and suggested research. This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the anthrax attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; current anthrax vaccine information; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination.
UR - http://www.scopus.com/inward/record.url?scp=0036569530&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036569530&partnerID=8YFLogxK
U2 - 10.1001/jama.287.17.2236
DO - 10.1001/jama.287.17.2236
M3 - Review article
C2 - 11980524
AN - SCOPUS:0036569530
SN - 0098-7484
VL - 287
SP - 2236
EP - 2252
JO - JAMA
JF - JAMA
IS - 17
ER -